Thermo Fisher Scientific India recognized as 'Great Place to Work' for fourth consecutive year
Great Place to Work Certification is the most definitive 'Employer-of-Choice' recognition that organizations aspire to achieve.
New Delhi: Thermo Fisher Scientific India, has cemented its place among the best workplaces in India. For the fourth straight year, it has been recognized by the Great Place to Work Institute (GPTW) for sustaining a High-Trust, High-Performance Culture.
Over the last three months, Thermo Fisher was evaluated on various matrices that included credibility, fairness, respect, and camaraderie, among others, through a comprehensive assessment process to measure the employee satisfaction index.
"This honor is a testimony of our deep-rooted culture defined by our corporate values. I am proud of our team who strive to build a conducive work environment through meaningful strategies and actions, every day. It also reflects the collective effort of every colleague at Thermo Fisher, in driving our Mission - to enable customers to make the world healthier, cleaner and safer," said Amit Chopra, Managing Director, India and South Asia.
Great Place to Work Certification is the most definitive 'Employer-of-Choice' recognition that organizations aspire to achieve. The certification is recognized the world over by colleagues and organizations alike and is considered the 'Gold Standard' in identifying and recognizing Great Workplace Cultures. Every year, more than 10,000 organizations across the world partner with the Great Places to Work Institute for assessment, benchmarking, and action planning to strengthen their workplace culture.
Ranked at 92, on the Fortune 500 list, Thermo Fisher Scientific has many awards and accolades to its credit both in India and globally. In 2021, Thermo Fisher was recognized among India's Best Workplaces in Biotechnology and Pharmaceutical Industry by the Great Place to Work Institute, and the Best Workplace for Women by The Economic Times, among many other noteworthy honors.
Read also: Thermo Fisher Scientific bags USFDA nod for NGS-based CDx Test for lung, thyroid cancers
